These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15765830)

  • 1. Blood dyscrasia with quetiapine and ziprasidone.
    Nair P; Lippmann S
    Psychosomatics; 2005; 46(1):89-90. PubMed ID: 15765830
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole, ziprasidone, and quetiapine in the treatment of first-episode nonaffective psychosis: results of a 6-week, randomized, flexible-dose, open-label comparison.
    Crespo-Facorro B; Pérez-Iglesias R; Mata I; Ortiz-Garcia de la Foz V; Martínez-Garcia O; Valdizan EM; Vazquez-Barquero JL
    J Clin Psychopharmacol; 2013 Apr; 33(2):215-20. PubMed ID: 23422371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease].
    López del Val LJ; Santos S
    Rev Neurol; 2004 Oct 1-15; 39(7):661-7. PubMed ID: 15490355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone in Parkinson's disease psychosis.
    Connemann BJ; Schönfeldt-Lecuona C
    Can J Psychiatry; 2004 Jan; 49(1):73. PubMed ID: 14763682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of quetiapine use in the management of ketamine-benzodiazepine coma therapy side-effects.
    White A; Brown TM
    Psychosomatics; 2012; 53(1):92-5. PubMed ID: 22221726
    [No Abstract]   [Full Text] [Related]  

  • 9. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 10. Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: a case report.
    Stephani C; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):790-1. PubMed ID: 20198646
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ziprasidone in Parkinsonian dopamine psychosis].
    Durán-Ferreras E; Alvarez-López M; García-Moreno JM; Chacón J
    Rev Neurol; 2008 Apr 16-30; 46(8):476-80. PubMed ID: 18428105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine for l-dopa-induced psychosis in PD.
    Fernandez HH
    Neurology; 2000 Sep; 55(6):899. PubMed ID: 10994027
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of a case of steroid-induced psychosis and inappropriate sexual behaviour in an adolescent.
    Demir T; Karacetin G; Dogangun B; Kocabasoglu N
    Pharmacopsychiatry; 2012 Mar; 45(2):77-9. PubMed ID: 22086740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
    Moteshafi H; Stip E
    Expert Opin Drug Saf; 2012 Sep; 11(5):713-32. PubMed ID: 22913713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone in autism.
    Alessi NE
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):622-3. PubMed ID: 12921465
    [No Abstract]   [Full Text] [Related]  

  • 17. Ziprasidone therapy for post-traumatic stress disorder.
    Siddiqui Z; Marcil WA; Bhatia SC; Ramaswamy S; Petty F
    J Psychiatry Neurosci; 2005 Nov; 30(6):430-1. PubMed ID: 16327877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of relative receptor binding affinity: quetiapine and ziprasidone as examples.
    Preskorn SH
    J Psychiatr Pract; 2007 Nov; 13(6):393-8. PubMed ID: 18032984
    [No Abstract]   [Full Text] [Related]  

  • 19. Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.
    Yalcin DO; Goka E; Aydemir MC; Kisa C
    J Psychopharmacol; 2008 May; 22(3):333-5. PubMed ID: 18208928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.